TY - JOUR
T1 - Association of US centers for medicare and medicaid services hospital 30-day risk-standardized readmission metric with care quality and outcomes after acute myocardial infarction
AU - Pandey, Ambarish
AU - Golwala, Harsh
AU - Hall, Hurst M.
AU - Wang, Tracy Y.
AU - Lu, Di
AU - Xian, Ying
AU - Chiswell, Karen
AU - Joynt, Karen E.
AU - Goyal, Abhinav
AU - Das, Sandeep R.
AU - Kumbhani, Dharam
AU - Julien, Howard
AU - Fonarow, Gregg C.
AU - De Lemos, James A.
N1 - Funding Information:
completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Wang has received research grants through Duke Clinical Research Institute from AstraZeneca, Boston Scientific, Bristol-Myers Squibb, Daiichi-Sankyo, Eli Lilly, Gilead Sciences, GlaxoSmithKline, Regeneron Pharmaceuticals, and Pfizer and has received consulting fees or honoraria from AstraZeneca, Eli Lilly, Pfizer, Merck, and Premier. Dr Wang has also received a grant from the American College of Cardiology. Dr Xian reported receiving research funding directed to the Duke Clinical Research Institute from the American Heart Association, Daiichi Sankyo, Janssen Pharmaceutical Companies, and Genentech. Dr Joynt serves as an advisor to the US Department of Health and Human Services. Dr Kumbhani has received research grants and honoraria from the American College of Cardiology. Dr Fonarow has received research support from the Agency for Healthcare Research and Quality and National Institutes of Health, as well as consulting fees from Amgen, Baxter, Bayer, Janssen, Novartis, and Medtronic. Dr de Lemos has received grant support from Abbott Diagnostics and Roche Diagnostics, consulting fees for membership on a data and safety monitoring board from St Jude Medical, and personal fees from Siemens Healthcare Diagnostics. No other disclosures were reported.
Publisher Copyright:
© 2017 American Medical Association. All rights reserved.
PY - 2017/7
Y1 - 2017/7
N2 - IMPORTANCE The US Centers for Medicare and Medicaid Services Hospital Readmissions Reduction Program penalizes hospitals with higher-than-expected risk-adjusted 30-day readmission rates (excess readmission ratio [ERR] > 1) after acutemyocardial infarction (MI). However, the association of ERR with MI care processes and outcomes are notwell established. OBJECTIVE To evaluate the association between ERR forMI with in-hospital process of care measures and 1-year clinical outcomes. DESIGN, SETTING, AND PARTICIPANTS Observational analysis of hospitalized patients with MI from National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines centers subject to the first cycle of the Hospital Readmissions Reduction Program between July 1, 2008, and June 30, 2011. EXPOSURES The ERR forMI (MI-ERR) in 2011. MAIN OUTCOMES AND MEASURES Adherence to process of care measures during index hospitalization in the overall study population and risk of the composite outcome of mortality or all-cause readmission within 1 year of discharge and its individual components among participants with available Centers for Medicare and Medicaid Services-linked data. RESULTS The median ages of patients in the MI-ERR greater than 1 and tertiles 1, 2, and 3 of the MI-ERR greater than 1 groupswere 64, 63, 64, and 63 years, respectively. Among 380 hospitals that treated a total of 176 644 patients with MI during the study period, 43%had MI-ERR greater than 1. The proportions of patients of black race, those with heart failure signs at admission, and bleeding complications increased with higher MI-ERR. Therewas no significant association between adherence to MI performance measures and MI-ERR (adjusted odds ratio, 0.94; 95%CI, 0.81-1.08, per 0.1-unit increase in MI-ERR for overall defect-free care). Among the 51 453 patients with 1-year outcomes data available, higher MI-ERRwas associated with higher adjusted risk of the composite outcome and all-cause readmission within 1 year of discharge. This associationwas largely driven by readmissions early after discharge andwas not significant in landmark analyses beginning 30 days after discharge. The MI-ERRwas not associated with risk for mortality within 1 year of discharge in the overall and 30-day landmark analyses. CONCLUSIONS AND RELEVANCE During the first cycle of the Hospital Readmissions Reduction Program, participating hospitals' risk-adjusted 30-day readmission rates followingMI were not associated with in-hospital quality ofMI care or clinical outcomes occurring after the first 30 days after discharge.
AB - IMPORTANCE The US Centers for Medicare and Medicaid Services Hospital Readmissions Reduction Program penalizes hospitals with higher-than-expected risk-adjusted 30-day readmission rates (excess readmission ratio [ERR] > 1) after acutemyocardial infarction (MI). However, the association of ERR with MI care processes and outcomes are notwell established. OBJECTIVE To evaluate the association between ERR forMI with in-hospital process of care measures and 1-year clinical outcomes. DESIGN, SETTING, AND PARTICIPANTS Observational analysis of hospitalized patients with MI from National Cardiovascular Data Registry/Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines centers subject to the first cycle of the Hospital Readmissions Reduction Program between July 1, 2008, and June 30, 2011. EXPOSURES The ERR forMI (MI-ERR) in 2011. MAIN OUTCOMES AND MEASURES Adherence to process of care measures during index hospitalization in the overall study population and risk of the composite outcome of mortality or all-cause readmission within 1 year of discharge and its individual components among participants with available Centers for Medicare and Medicaid Services-linked data. RESULTS The median ages of patients in the MI-ERR greater than 1 and tertiles 1, 2, and 3 of the MI-ERR greater than 1 groupswere 64, 63, 64, and 63 years, respectively. Among 380 hospitals that treated a total of 176 644 patients with MI during the study period, 43%had MI-ERR greater than 1. The proportions of patients of black race, those with heart failure signs at admission, and bleeding complications increased with higher MI-ERR. Therewas no significant association between adherence to MI performance measures and MI-ERR (adjusted odds ratio, 0.94; 95%CI, 0.81-1.08, per 0.1-unit increase in MI-ERR for overall defect-free care). Among the 51 453 patients with 1-year outcomes data available, higher MI-ERRwas associated with higher adjusted risk of the composite outcome and all-cause readmission within 1 year of discharge. This associationwas largely driven by readmissions early after discharge andwas not significant in landmark analyses beginning 30 days after discharge. The MI-ERRwas not associated with risk for mortality within 1 year of discharge in the overall and 30-day landmark analyses. CONCLUSIONS AND RELEVANCE During the first cycle of the Hospital Readmissions Reduction Program, participating hospitals' risk-adjusted 30-day readmission rates followingMI were not associated with in-hospital quality ofMI care or clinical outcomes occurring after the first 30 days after discharge.
UR - http://www.scopus.com/inward/record.url?scp=85031672770&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85031672770&partnerID=8YFLogxK
U2 - 10.1001/jamacardio.2017.1143
DO - 10.1001/jamacardio.2017.1143
M3 - Article
C2 - 28445559
AN - SCOPUS:85031672770
SN - 2380-6583
VL - 2
SP - 723
EP - 731
JO - JAMA Cardiology
JF - JAMA Cardiology
IS - 7
ER -